(Q55067941)

16 June 2018

review article

1 reference

title

Toxin-mediated streptococcal and staphylococcal disease. (English)

1 reference

16 June 2018

author name string

Manders SM

series ordinal

1

1 reference

16 June 2018

language of work or name

English

0 references

publication date

1 September 1998

1 reference

16 June 2018

Journal of the American Academy of Dermatology

published in

1 reference

16 June 2018

volume

39

1 reference

16 June 2018

page(s)

383-98; quiz 399-400

1 reference

16 June 2018

issue

3

1 reference

16 June 2018

Comprehensive review of morbidity and mortality trends for rheumatic fever, streptococcal disease, and scarlet fever: the decline of rheumatic fever

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Apparent increase in the incidence of invasive group A beta-hemolytic streptococcal disease in children

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

The reemergence of serious group A streptococcal infections and acute rheumatic fever.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

A recalcitrant, erythematous, desquamating disorder associated with toxin-producing staphylococci in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Resurgence of acute rheumatic fever in the intermountain area of the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Severe streptococcal infections in historical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Outbreak of acute rheumatic fever in northeast Ohio

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

The return of acute rheumatic fever in young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Recurrent toxin-mediated perineal erythema

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Invasive group A streptococcus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

The toxic shock syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Hippocrates on necrotising fasciitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Selective Depletion Of V -Bearing T Cells In Patients With Severe Invasive Group A Streptococcal Infections And Streptococcal Toxic Shock Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Necrotizing fasciitis. The changing spectrum

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Group A streptococcal infections of the skin and pharynx (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Changing epidemiology of group A streptococcal infection in the USA.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Severe Invasive Group A Streptococcal Infections In Ontario, Canada: 1987-1991

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Correlation between serum TNF alpha and IL6 levels and severity of group A streptococcal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Genetic and phenotypic diversity among isolates of Streptococcus pyogenes from invasive infections

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Molecular characterization and phylogenetic distribution of the streptococcal superantigen gene (ssa) from Streptococcus pyogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Selective expansion of T cells expressing V beta 2 in toxic shock syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Interaction of Staphylococcus aureus toxin "superantigens" with human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Streptococcal toxic shock-like syndrome: evidence of superantigen activity and its effects on T lymphocyte subsets in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

The Vβ-specific superantigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal mice

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

1 reference

7 January 2021

Role of superantigens in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Superantigens interact with MHC class II molecules outside of the antigen groove.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Major histocompatibility complex class II-associated peptides determine the binding of the superantigen toxic shock syndrome toxin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

The staphylococcal enterotoxins and their relatives.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Superantigens: structure and relevance to human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Superantigens activate HIV-1 gene expression in monocytic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

1 reference

7 January 2021

Superantigens and their potential role in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Analysis of the interaction site for the self superantigen Mls-1a on T cell receptor V beta

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Bacterial superantigens induce V beta-specific T cell receptor internalization

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Superantigens: mechanism of T-cell stimulation and role in immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Production of tumor necrosis factor by human monocytes in response to toxic-shock-syndrome toxin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Molecular structure of staphylococcus and streptococcus superantigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Induction by toxic-shock-syndrome toxin-1 of a circulating tumor necrosis factor-like substance in rabbits and of immunoreactive tumor necrosis factor and interleukin-1 from human mononuclear cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Streptococcal toxic shock syndrome: synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Production of Staphylococcal Pyrogenic Exotoxin Type C: Influence of Physical and Chemical Factors

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Phenotypic distinctiveness of Staphylococcus aureus strains associated with toxic shock syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Effect of Magnesium on Production of Toxic-Shock-Syndrome Toxin-1: A Collaborative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Bacterial superantigens--mechanism of T cell activation by the superantigens and their role in the pathogenesis of infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Cross-neutralization of staphylococcal and streptococcal pyrogenic toxins by monoclonal and polyclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Nucleotide sequence of the staphylococcal enterotoxin C1 gene and relatedness to other pyrogenic toxins

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Streptococcal pyrogenic exotoxin type A (scarlet fever toxin) is related to Staphylococcus aureus enterotoxin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Toxic-shock syndrome associated with phage-group-I Staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

1 reference

7 January 2021

Active surveillance for toxic shock syndrome in the United States, 1986.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Toxic shock syndrome. A newly recognized complication of influenza and influenzalike illness

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Nonmenstrual toxic shock syndrome in a young child with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Toxic shock syndrome as the AIDS-defining diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

The acquired immunodeficiency syndrome and nonmenstrual toxic shock syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

The human immunodeficiency virus and nonmenstrual toxic shock syndrome: a female case presentation.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Toxic shock syndrome surveillance in the United States, 1980 to 1981

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Toxic shock syndrome associated with Staphylococcus aureus sinusitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Toxic shock syndrome: clinical, laboratory, and pathologic findings in nine fatal cases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

The effect of topical antimicrobial agents on the production of toxic shock syndrome toxin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Production of staphylococcal enterotoxin F and pyrogenic exotoxin C by Staphylococcus aureus isolates from toxic shock syndrome-associated sources

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Induction of human interleukin-1 by toxic-shock-syndrome toxin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Antibody responses to toxic-shock-syndrome (TSS) toxin by patients with TSS and by healthy staphylococcal carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

A new type of mitogenic factor produced by Streptococcus pyogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Acute group G streptococcal myositis associated with streptococcal toxic shock syndrome: case report and review.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Congenital streptococcal toxic shock syndrome with absence of antibodies against streptococcal pyrogenic exotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Group A beta-hemolytic streptococcal toxic shock-like syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Streptococcal toxic shock-like syndrome as a complication of varicella

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Varicella gangrenosa with toxic shock-like syndrome due to group A streptococcus infection in an adult: case report

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Streptococcal toxic shock-like syndrome. The importance of surgical intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Recurrent attacks of scarlet fever

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Staphylococcal scalded skin syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Staphylococcal scalded skin syndrome in a homosexual adult

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Staphylococcal scalded skin syndrome in adults. A clinical review illustrated with a new case.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

"Flesh-eating bacteria": return of an old nemesis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Aerobic and anaerobic microbiology of necrotizing fasciitis in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Necrotizing fasciitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Rapid identification of group A streptococcus as the cause of necrotizing fasciitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Diagnosis and management of Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

1 reference

7 January 2021

Acute febrile mucocutaneous lymph node (Kawasaki) syndrome. An analysis of 24 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Superantigens in Kawasaki syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

The perineal eruption of Kawasaki syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Small pustules in Kawasaki disease. A clinicopathological study of four patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

1 reference

7 January 2021

The potential role of bacterial superantigens in the pathogenesis of Kawasaki syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Characterization of T cell repertoire changes in acute Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Evidence for a superantigen mediated process in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Susceptible responsiveness to bacterial superantigens in peripheral blood mononuclear cells from patients with psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

ACUTE GUTTATE PSORIASIS AND STREPTOCOCCAL INFECTION

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Acute psoriasis associated with Lancefield Group C and Group G cutaneous streptococcal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Isolation and Partial Characterization of a Keratinocyte Proliferative Factor Produced by Streptococcus pyogenes (Strain NY-5)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

The Koebner phenomenon and the microbial basis of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Group A streptococcal antigen-specific T lymphocytes in guttate psoriatic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Restricted T-cell receptor V beta gene usage in the skin of patients with guttate and chronic plaque psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Differential expression of lymphocyte homing receptors by human memory/effector T cells in pulmonary versus cutaneous immune effector sites.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

CD8+ T cells in psoriatic lesions preferentially use T-cell receptor V beta 3 and/or V beta 13.1 genes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Staphylococcus aureus in the lesions of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Superantigenic exotoxin-secreting potential of staphylococci isolated from atopic eczematous skin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Cutaneous exposure to the superantigen staphylococcal enterotoxin B elicits a T-cell-dependent inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

Interferon Gamma-Treated Keratinocytes Activate T Cells in the Presence of Superantigens: Involvement of Major Histocompatibility Complex Class II Molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970314-7

7 January 2021

10.1016/S0190-9622(98)70314-7

Identifiers

DOI

1 reference

16 June 2018

release_hww3wnhwq5fcnetsvuzi2ojtua

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hww3wnhwq5fcnetsvuzi2ojtua

24 November 2022

mapped directly with Wikidata item

PubMed ID

9738772

1 reference

16 June 2018